Biolargo, Inc. SEC filings BLGO
Biolargo, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 29, 2005. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 19, 2026 | Dec 1, 2026 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 19, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2025 | Jun 19, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 13, 2024 |
| DEF 14A | Proxy statement | Apr 21, 2023 | Jun 6, 2023 |
| DEF 14A | Proxy statement | Apr 18, 2022 | Jun 2, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2022 | Apr 4, 2022 |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 15, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2021 | Apr 1, 2021 |
| DEFA14A | Additional proxy material | Jul 20, 2020 | — |
| DEF 14A | Proxy statement | May 27, 2020 | Jul 23, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 28, 2020 | Jul 23, 2020 |
| DEF 14A | Proxy statement | Jun 12, 2019 | Jul 31, 2019 |
| PRE 14A | Preliminary proxy statement | May 24, 2019 | Jul 23, 2019 |
| DEF 14A | Proxy statement | Aug 15, 2018 | Sep 26, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 3, 2018 | Sep 26, 2018 |
| DEF 14A | Proxy statement | Apr 4, 2018 | May 23, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2018 | May 7, 2018 |
| DEF 14A | Proxy statement | May 1, 2017 | Jun 19, 2017 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 20, 2016 |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 24, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 23, 2014 |
| DEF 14A | Proxy statement | Apr 30, 2013 | Jun 17, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Jun 25, 2012 |
| DEF 14C | Information statement | May 2, 2011 | Apr 29, 2011 |
| DEF 14C | Information statement | Apr 30, 2010 | Apr 30, 2010 |
| DEF 14C | Information statement | Apr 30, 2009 | May 15, 2009 |
| DEF 14C | Information statement | Apr 29, 2008 | Apr 29, 2008 |
| DEF 14A | Proxy statement | Aug 13, 2007 | Sep 6, 2007 |
| DEF 14A | Proxy statement | Feb 13, 2007 | Mar 15, 2007 |
| PRE 14A | Preliminary proxy statement | Nov 3, 2006 | Dec 20, 2006 |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- BLGO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westminster, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 880242
- Former names
- NUWAY MEDICAL INC (until Apr 3, 2007); NUWAY ENERGY INC (until Feb 5, 2003); LATIN AMERICAN CASINOS INC (until Feb 15, 2001)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- Chemours Co CC
- OLIN Corp OLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.